Sponsor:
Indiana University
Code:
NCT04506593
Conditions
Eosinophilic Esophagitis
Gastroesophageal Reflux Disease (GERD)
Gastroparesis
Functional Vomiting
Irritable Bowel Syndrome (IBS)
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
no intervention
Brief summary:
Conditions
Eosinophilic Esophagitis
Gastroesophageal Reflux Disease (GERD)
Gastroparesis
Functional Vomiting
Irritable Bowel Syndrome (IBS)
Study ID
NCT04506593
Start date
Nov 1, 2014
Status verified date
Aug, 2025
Completion date
Nov, 2026
Anticipated
Primary completion date
Nov, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
5000 participants
Anticipated
Interventions
no intervention
Primary outcome measure
Central contacts
Maureen Schilling
maschi@iu.eduLocations
Indiana University Health University Hospital
Recruiting
Indianapolis, Indiana, United States, 46202
Contacts
Principal Investigator:
John Wo, MD
Sponsor
Indiana University
Last update posted
Jun 16, 2026
Last verified
Aug, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Indiana University on 2026-06-16.